Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

Impact · against what's priced in

The news is largely a confirmation of known trajectories for Medtronic, with the share retirement and dividend streak already reflected in the current valuation. MiniMed's post-spin-off price weakness is a negative signal for the new entity, though not surprising given the separation.

MDT+0.00: Already priced in
The price assumes: The full financial benefit of the MiniMed separation

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

What matters in this story

Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

What matters in this story

Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth

How each ticker is affected

Connected tickers

Track these names every morning.

Starbucks: 3 Key Takeaways for Long-Term Investors

AbbVie: 3 Key Takeaways for Long-Term Investors

BNP Paribas: The Market Leader That Keeps On Performing

Micron's Chinese Rival CXMT Just Grew Its Sales More Than Sevenfold. I'd Buy Micron Stock Now.

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

What matters in this story

Next reads from the same story arc

Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

What matters in this story

Next reads from the same story arc

Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth

How each ticker is affected

Connected tickers

Track these names every morning.

Starbucks: 3 Key Takeaways for Long-Term Investors

AbbVie: 3 Key Takeaways for Long-Term Investors

BNP Paribas: The Market Leader That Keeps On Performing

Micron's Chinese Rival CXMT Just Grew Its Sales More Than Sevenfold. I'd Buy Micron Stock Now.